New York State Common Retirement Fund
CTMX icon

New York State Common Retirement Fund’s CytomX Therapeutics CTMX Stock Holding History

New York State Common Retirement Fund’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+35,700
New +$136K ﹤0.01% 2542
2022
Q3 		– Sell
-445
Closed -$1K – 3307
2022
Q2 		$1K Sell
445
-30,158
-99% -$57.7K ﹤0.01% 3334
2022
Q1 		$82K Buy
30,603
+91
+0.3% +$349 ﹤0.01% 3069
2021
Q4 		$132K Sell
30,512
-143
-0.5% -$838 ﹤0.01% 3007
2021
Q3 		$156K Sell
30,655
-18,828
-38% -$101K ﹤0.01% 2995
2021
Q2 		$313K Buy
49,483
+6,483
+15% +$50.5K ﹤0.01% 2825
2021
Q1 		$332K Sell
43,000
-9,127
-18% -$72.2K ﹤0.01% 2651
2020
Q4 		$341K Sell
52,127
-13,900
-21% -$99.3K ﹤0.01% 2529
2020
Q3 		$439K Hold
66,027
– – ﹤0.01% 2268
2020
Q2 		$550K Buy
66,027
+18,483
+39% +$172K ﹤0.01% 2154
2020
Q1 		$365K Sell
47,544
-1,883
-4% -$13.1K ﹤0.01% 2193
2019
Q4 		$411K Sell
49,427
-1,400
-3% -$9.45K ﹤0.01% 2396
2019
Q3 		$375K Buy
50,827
+1,200
+2% +$11.8K ﹤0.01% 2477
2019
Q2 		$557K Sell
49,627
-350
-0.7% -$3.67K ﹤0.01% 2325
2019
Q1 		$537K Sell
49,977
-550
-1% -$8.13K ﹤0.01% 2270
2018
Q4 		$763K Sell
50,527
-1,250
-2% -$18.5K ﹤0.01% 2057
2018
Q3 		$958K Sell
51,777
-5,800
-10% -$132K ﹤0.01% 2116
2018
Q2 		$1.32M Buy
57,577
+10,680
+23% +$273K ﹤0.01% 1941
2018
Q1 		$1.33M Buy
46,897
+4,420
+10% +$126K ﹤0.01% 1858
2017
Q4 		$897K Buy
42,477
+5,577
+15% +$116K ﹤0.01% 2096
2017
Q3 		$670K Buy
36,900
+5,800
+19% +$90.5K ﹤0.01% 2213
2017
Q2 		$482K Buy
31,100
+10,199
+49% +$154K ﹤0.01% 2427
2017
Q1 		$361K Buy
20,901
+1
+0% +$13 ﹤0.01% 2534
2016
Q4 		$230K Hold
20,900
– – ﹤0.01% 2720
2016
Q3 		$328K Hold
20,900
– – ﹤0.01% 2540
2016
Q2 		$213K Buy
20,900
+13,600
+186% +$155K ﹤0.01% 2696
2016
Q1 		$94K Buy
+7,300
New +$101K ﹤0.01% 2940

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

New York State Common Retirement Fund's CTMX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 35,700 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #2542 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in CTMX as recently as Q2 2022.

New York State Common Retirement Fund first reported a position in CTMX in Q1 2016 and has held it in 27 quarters since. The position peaked at $1.33M in Q1 2018. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • New York State Common Retirement Fund held 35,700 shares of CytomX Therapeutics worth $134K as of Q2 2026.
  • CytomX Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • CytomX Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2542 holding.
  • New York State Common Retirement Fund first reported a position in CytomX Therapeutics in Q1 2016 and has held it in 27 quarters since.
  • New York State Common Retirement Fund's CytomX Therapeutics position peaked at $1.33M in Q1 2018.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.